Comment
Author: Admin | 2025-04-28
Shares, with the remaining 43% issued to Mylan shareholders. The Viatris drug portfolio includes:EpiPen, epinephrine auto-injector for severe allergic reactionsLipitor, atorvastatin, a cholesterol-lowering medicationViagra, sildenafil, used for erectile dysfunctionCelebrex, celecoxib, a nonsteroidal anti-inflammatory drugEffexor XR, venlafaxine extended release, an antidepressantNeurontin, gabapentin, used for epilepsy and nerve pain)Zoloft, sertraline, an antidepressantLyrica, pregabalin, used to treat fibromyalgia, nerve pain, and certain seizuresPfizer and COVID-19Pfizer joined forces with BioNTEch in March 2020 to develop an mRNA vaccine for COVID-19, a devastating virus that killed millions worldwide. Rather than accept money from the U.S. government for this initiative, Pfizer CEO Albert Bourla opted to use $2 billion of the company’s money in an effort to avoid government interference. Four vaccine variations were developed, and two given the go-ahead for human testing by the Food and Drug Administration. One of the vaccines offered a 95% efficacy rate, as announced by Pfizer in November 2020, and the vaccine was quickly approved by several nations, including the United States.In 2021, Pfizer complemented its COVID-19 vaccine with an oral antivirus treatment called Paxlovid, which proved to be effective for reducing symptom severity and keeping COVID-19 patients out of the hospital.Lawsuits and recallsPfizer has faced numerous lawsuits and recalls since its founding. In June 2022, for example, the company recalled the 0.5 mg and 1 mg tablets of its popular smoking cessation drug Chantix due to unacceptable levels of the cancer-causing compound N-nitroso-varenicline, and expanded the recall further in 2023. Years earlier, an estimated 3,000 people filed suit against Pfizer over Chantix, alleging suicidal ideation and other psychological disorders. In 2013, Pfizer put nearly $288 million aside to settle claims.Pfizer holds the dubious distinction of paying the largest settlement in the history of the U.S. Justice Department for health care fraud: $2.3 billion. The settlement was finalized in 2009
Add Comment